The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction
Open accessAbstract
BACKGROUND: Interleukin-6 (IL-6) has an important role in cancer progression, and high levels of plasma IL-6 are correlated with a poor prognosis in a variety of cancers. It has also been reported that tumour stromal fibroblasts are necessary for steps in cancer progression, such as angiogenesis. There have been few reports of a correlation between fibroblast actions and IL-6 levels. In this study, we examined the correlation between cancer stromal fibroblasts and IL-6 and the utility of IL-6 as a therapeutic target in human colon cancer. METHODS: The expression levels of IL-6 and VEGF of fibroblasts and cancer cell lines were evaluated using real-time PCR and ELISA. The anti-angiogenic effect of inhibiting IL-6 signalling was measured in an angiogenesis model and animal experiment. RESULTS: We demonstrate that stromal fibroblasts isolated from colon cancer produced significant amounts of IL-6 and that colon cancer cells enhanced IL-6 production by stromal fibroblasts. Moreover, IL-6 enhanced VEGF production by fibroblasts, thereby inducing angiogenesis. In vivo, anti-IL6 receptor antibody targeting stromal tissue showed greater anti-tumour activity than did anti-IL6 receptor antibody targeting xenografted cancer cells. CONCLUSION: Cancer stromal fibroblasts were an important source of IL-6 in colon cancer. IL-6 produced by activated fibroblasts induced tumour angiogenesis by stimulating adjacent stromal fibroblasts. The relationship between IL-6 and stromal fibroblasts offers new approaches to cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Interleukin-6 family of cytokines and gp130
Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995) · Blood · doi:10.1182/blood.v86.4.1243.bloodjournal8641243 · Cited by 1,272
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Wang, T., Sinibaldi, D., Coppola, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205260 · Cited by 1,207
Rose-John, S. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4989 · Cited by 1,040
Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells
Mishra, P. J., Mishra, P. J., Humeniuk, R., Medina, D. J., Alexe, G., Mesirov, J. P., Ganesan, S., Glod, J. W., & Banerjee, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0943 · Cited by 912
Interleukin-6 signaling pathway in targeted therapy for cancer
Guo, Y., Xu, F., Lu, T., Duan, Z., & Zhang, Z. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.04.007 · Cited by 686
Loeffler, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26532 · Cited by 633
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks
Liu, S., Ginestier, C., Ou, S. J., Clouthier, S. G., Patel, S. H., Monville, F., Korkaya, H., Heath, A., Dutcher, J., Kleer, C. G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0538 · Cited by 611
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
Uzzan, B., Nicolas, P., Cucherat, M., & Perret, G.-Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1957 · Cited by 468
Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
Coward, J., Kulbe, H., Chakravarty, P., Leader, D., Vassileva, V., Leinster, D. A., Thompson, R., Schioppa, T., Nemeth, J., Vermeulen, J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0945 · Cited by 390
Interleukin-6 in bone metastasis and cancer progression
Ara, T., & DeClerck, Y. A. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.026 · Cited by 379
Interleukin-6, Secreted by Human Ovarian Carcinoma Cells, Is a Potent Proangiogenic Cytokine
Nilsson, M. B., Langley, R. R., & Fidler, I. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0623 · Cited by 349
An in vitro model of angiogenesis: Basic features
Bishop, E. T., Bell, G. T., Bloor, S., Broom, I. J., Hendry, N. F. K., & Wheatley, D. N. (1999) · Angiogenesis · doi:10.1023/a:1026546219962 · Cited by 307
Anglesio, M. S., George, J., Kulbe, H., Friedlander, M., Rischin, D., Lemech, C., Power, J., Coward, J., Cowin, P. A., House, C. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3314 · Cited by 258
Zhang, Y., Tang, H., Cai, J., Zhang, T., Guo, J., Feng, D., & Wang, Z. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.011 · Cited by 242
The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis
Hashizume, M., & Mihara, M. (2011) · Arthritis · doi:10.1155/2011/765624 · Cited by 238
Nakagawa, H., Liyanarachchi, S., Davuluri, R. V., Auer, H., Martin, E. W., de la Chapelle, A., & Frankel, W. L. (2004) · Oncogene · doi:10.1038/sj.onc.1208013 · Cited by 231
Powell, D. W., Adegboyega, P. A., Di Mari, J. F., & Mifflin, R. C. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00075.2005 · Cited by 223
Garbers, C., Thaiss, W., Jones, G. W., Waetzig, G. H., Lorenzen, I., Guilhot, F., Lissilaa, R., Ferlin, W. G., Grötzinger, J., Jones, S. A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295758 · Cited by 191
Signaling Pathways Governing Tumor Angiogenesis
Sakurai, T., & Kudo, M. (2011) · Oncology · doi:10.1159/000333256 · Cited by 190
IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines
Liu, Q., Li, G., Li, R., Shen, J., He, Q., Deng, L., Zhang, C., & Zhang, J. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0158-0 · Cited by 160
Wu, M., Hong, H.-C., Hong, T.-M., Chiang, W.-F., Jin, Y., & Chen, Y. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1824 · Cited by 151
Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells
Fuyuhiro, Y., Yashiro, M., Noda, S., Kashiwagi, S., Matsuoka, J., Doi, Y., Kato, Y., Hasegawa, T., Sawada, T., & Hirakawa, K. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.330 · Cited by 121
Santer, F. R., Malinowska, K., Čulig, Z., & Cavarretta, I. T. R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0200 · Cited by 120
Hugo, H. J., Lebret, S. C., Tomaskovic‐Crook, E., Ahmed, N., Blick, T., Newgreen, D. F., Thompson, E. W., & Ackland, M. L. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0098-7 · Cited by 92
Shinagawa, K., Kitadai, Y., Tanaka, M., Sumida, T., Onoyama, M., Ohnishi, M., Ohara, E., Higashi, Y., Tanaka, S., Yasui, W., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27735 · Cited by 88
Shao, J., Sheng, G. G., Mifflin, R. C., Powell, D. W., & Sheng, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2606 · Cited by 88
Cancer-Stromal Cell Interaction and Tumor Angiogenesis in Gastric Cancer
Kitadai, Y. (2009) · Cancer Microenvironment · doi:10.1007/s12307-009-0032-9 · Cited by 81
Fujita, H., Ohuchida, K., Mizumoto, K., Egami, T., Miyoshi, K., Moriyama, T., Cui, L., Yu, J., Zhao, M., Manabe, T., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01317.x · Cited by 81
Paland, N., Kamer, I., Kogan-Sakin, I., Madar, S., Goldfinger, N., & Rotter, V. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0073 · Cited by 73
Suzuki, M., Hashizume, M., Yoshida, H., & Mihara, M. (2009) · Rheumatology International · doi:10.1007/s00296-009-0953-0 · Cited by 71
Semba, S., Kodama, Y., Ohnuma, K., Mizuuchi, E., Masuda, R., Yashiro, M., Hirakawa, K., & Yokozaki, H. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605309 · Cited by 64
Stromal Fibroblasts in Digestive Cancer
Worthley, D. L., Giraud, A. S., & Wang, T. C. (2010) · Cancer Microenvironment · doi:10.1007/s12307-009-0033-8 · Cited by 57
Hara, M., Nakanishi, H., Tsujimura, K., Matsui, M., Yatabe, Y., Manabe, T., & Tatematsu, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00821.x · Cited by 54
Self-citationYeh, K., Li, Y., Hsieh, L., Lu, C. H., Chou, W., Liaw, C., Tang, R., & Liao, S. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyq010 · Cited by 53
Oguro, T., Ishibashi, K., Sugino, T., Hashimoto, K., Tomita, S., Takahashi, N., Yanagida, T., Haga, N., Aikawa, K., Suzutani, T., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.11.038 · Cited by 50
Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cells
Hsu, C., Chen, Y., Huang, C.-C., Chou, C.-C., Liu, C., Hung, C., Kao, T., & Chung, Y. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02405.x · Cited by 42
Okugawa, Y., Miki, C., Toiyama, Y., Yasuda, H., Yokoe, T., Saigusa, S., Hiro, J., Tanaka, K., Inoue, Y., & Kusunoki, M. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605827 · Cited by 24
Role of bone marrow-derived cells in colon cancer: lessons from mouse model studies
Taketo, M. M. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-008-2321-3 · Cited by 18
Herbut, P. A., & Kraemer, W. H. (1955) · PubMed · Cited by 7
Cited by
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110
Role of interleukin-6 in cancer progression and therapeutic resistance
Kumari, N., Dwarakanath, B. S., Das, A., & Bhatt, A. N. (2016) · Tumor Biology · doi:10.1007/s13277-016-5098-7 · Cited by 1,092
IL-6 pathway in the liver: From physiopathology to therapy
Schmidt-Arras, D., & Rose-John, S. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.004 · Cited by 881
Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H. (2015) · Cancers · doi:10.3390/cancers7040902 · Cited by 774
Self-citationMicroenvironmental regulation of therapeutic response in cancer
Klemm, F., & Joyce, J. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.006 · Cited by 771
Metadata
- Authors
- Nagasaki, T., Hara, M., Nakanishi, H., Takahashi, H., Sato, M., & Takeyama, H.
- Venue
- British Journal of Cancer
- Published
- 2013-12-17
- Volume
- 110
- Issue
- 2
- Pages
- 469-478
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2030797581
- Cited by
- 385
- References
- 41
- FWCI
- 9.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.